Abdul R Abdullah

Summary

Publications

  1. doi request reprint Advance hospital notification by EMS in acute stroke is associated with shorter door-to-computed tomography time and increased likelihood of administration of tissue-plasminogen activator
    Abdul R Abdullah
    Department of Neurology, Massachusetts General Hospital, and Harvard Medical School, Boston, Massachusetts, USA
    Prehosp Emerg Care 12:426-31. 2008
  2. doi request reprint Risk of thrombolytic therapy for acute ischemic stroke in patients with current malignancy
    Shihab Masrur
    Department of Neurology, Stroke Service, Massachusetts General Hospital, Boston, Massachusetts 02114, USA
    J Stroke Cerebrovasc Dis 20:124-30. 2011
  3. ncbi request reprint Serum lipid profile on admission for ischemic stroke: failure to meet National Cholesterol Education Program Adult Treatment Panel (NCEP-ATPIII) guidelines
    Eric E Smith
    Department of Neurology and Stroke Service, Massachusetts General Hospital, Boston, MA 02114, USA
    Neurology 68:660-5. 2007
  4. doi request reprint Stroke center designation can be achieved by small hospitals: the Massachusetts experience
    Eric E Smith
    Department of Neurology, Stroke Service, Massachusetts General Hospital, Boston, MA 02114, USA
    Crit Pathw Cardiol 7:173-7. 2008
  5. ncbi request reprint Poor outcomes in patients who do not receive intravenous tissue plasminogen activator because of mild or improving ischemic stroke
    Eric E Smith
    Department of Neurology, Massachusetts General Hospital, Boston, MA 02114, USA
    Stroke 36:2497-9. 2005

Collaborators

  • Iva Petkovska
  • Shihab Masrur
  • Eric E Smith
  • Lee H Schwamm
  • Paul Dreyer
  • Gail Palmeri
  • Janet Prvu-Bettger
  • Louise Goyette
  • Cathleen McElligott
  • Houman Amirfarzan
  • Eric Rosenthal
  • Walter J Koroshetz

Detail Information

Publications5

  1. doi request reprint Advance hospital notification by EMS in acute stroke is associated with shorter door-to-computed tomography time and increased likelihood of administration of tissue-plasminogen activator
    Abdul R Abdullah
    Department of Neurology, Massachusetts General Hospital, and Harvard Medical School, Boston, Massachusetts, USA
    Prehosp Emerg Care 12:426-31. 2008
    ....
  2. doi request reprint Risk of thrombolytic therapy for acute ischemic stroke in patients with current malignancy
    Shihab Masrur
    Department of Neurology, Stroke Service, Massachusetts General Hospital, Boston, Massachusetts 02114, USA
    J Stroke Cerebrovasc Dis 20:124-30. 2011
    ..Our data suggest that thrombolysis may be a reasonable option for patients with malignancy who have acceptable medical comorbidities and performance status. Further research is warranted...
  3. ncbi request reprint Serum lipid profile on admission for ischemic stroke: failure to meet National Cholesterol Education Program Adult Treatment Panel (NCEP-ATPIII) guidelines
    Eric E Smith
    Department of Neurology and Stroke Service, Massachusetts General Hospital, Boston, MA 02114, USA
    Neurology 68:660-5. 2007
    ..To determine the characteristics of patients with stroke/TIA whose admission low-density lipoprotein (LDL) levels were above goals defined by National Cholesterol Education Program Adult Treatment Panel (NCEP-ATPIII) guidelines...
  4. doi request reprint Stroke center designation can be achieved by small hospitals: the Massachusetts experience
    Eric E Smith
    Department of Neurology, Stroke Service, Massachusetts General Hospital, Boston, MA 02114, USA
    Crit Pathw Cardiol 7:173-7. 2008
    ..Innovative strategies, such as telemedicine consultation and transfer agreements, may successfully allow smaller hospitals to satisfy Brain Attack Coalition criteria for primary stroke centers...
  5. ncbi request reprint Poor outcomes in patients who do not receive intravenous tissue plasminogen activator because of mild or improving ischemic stroke
    Eric E Smith
    Department of Neurology, Massachusetts General Hospital, Boston, MA 02114, USA
    Stroke 36:2497-9. 2005
    ..Some patients with mild or improving ischemic stroke symptoms do not receive intravenous tissue plasminogen activator (tPA) because they look "too good to treat" (TGT); however, some have poor outcomes...